ADLER GROUP S.A.L0112A133LU290036313106/24/2026APPROVE STANDALONE FINANCIAL STATEMENTSCORPORATE GOVERNANCEISSUER837680FOR83768FOR19 ADLER GROUP S.A.L0112A133LU290036313106/24/2026APPROVE CONSOLIDATED FINANCIAL STATEMENTSCORPORATE GOVERNANCEISSUER837680FOR83768FOR19 ADLER GROUP S.A.L0112A133LU290036313106/24/2026APPROVE ALLOCATION OF LOSSCAPITAL STRUCTUREISSUER837680FOR83768FOR19 ADLER GROUP S.A.L0112A133LU290036313106/24/2026APPROVE DISCHARGE OF DIRECTORSDIRECTOR ELECTIONSISSUER837680FOR83768FOR19 ADLER GROUP S.A.L0112A133LU290036313106/24/2026APPOINT AVEGA REVISION S.A R.L. AS AUDITORAUDIT-RELATEDISSUER837680FOR83768FOR19 ADLER GROUP S.A.L0112A133LU290036313106/24/2026REELECT STEFAN BRENDGEN AS DIRECTORDIRECTOR ELECTIONSISSUER837680AGAINST83768AGAINST19 ADLER GROUP S.A.L0112A133LU290036313106/24/2026REELECT MATTHIAS MOSER AS DIRECTORDIRECTOR ELECTIONSISSUER837680AGAINST83768AGAINST19 ADLER GROUP S.A.L0112A133LU290036313106/24/2026APPROVE REMUNERATION REPORTSECTION 14A SAY-ON-PAY VOTESISSUER837680AGAINST83768AGAINST19 CONSTELLIUM SEF21107101FR001346747905/21/2026Ratification of the interim appointment of Ms. Ingrid Joerg as a directorDIRECTOR ELECTIONSISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Appointment of Ms. Ingrid Joerg as a director for a term of three years Ms. Ingrid JoergDIRECTOR ELECTIONSISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Re-appointment of Mr. John Ormerod as a director for a term of three years Mr. John OrmerodDIRECTOR ELECTIONSISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Approval, on an advisory (non-binding) basis, of the 2025 compensation of the Company's named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Advisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every yearSECTION 14A SAY-ON-PAY VOTESISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Advisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every two yearsSECTION 14A SAY-ON-PAY VOTESISSUER981910AGAINST98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Advisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every three yearsSECTION 14A SAY-ON-PAY VOTESISSUER981910AGAINST98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Approval of the statutory financial statements and transactions for the fiscal year ended December 31, 2025CORPORATE GOVERNANCEISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Approval of the consolidated financial statements and transactions for the fiscal year ended December 31, 2025CORPORATE GOVERNANCEISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Discharge (quitus) of the directors, the Chief Executive Officer, and the Statutory Auditors of the Company in respect of the performance of their duties for the fiscal year ended December 31, 2025DIRECTOR ELECTIONSAUDIT-RELATEDISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Allocation of the results of the Company for the fiscal year ended December 31, 2025CAPITAL STRUCTUREISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Approval of the aggregate maximum amount of the directors' annual fixed feesCOMPENSATIONISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Authorization to be given to the Board of Directors for the repurchase by the Company of its own shares in accordance with article L. 225-209-2 of the French Commercial CodeCAPITAL STRUCTUREISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Authorization to be given to the Board of Directors to reduce the Company's share capital by canceling shares acquired pursuant to the authorization for the Company to repurchase its own shares in accordance with the provisions of article L. 225-209-2 of the French Commercial CodeCAPITAL STRUCTUREISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Authorization to be given to the Board of Directors to reduce the Company's share capital by canceling the shares acquired by the Company pursuant to the provisions of article L. 225-208 of the French Commercial CodeCAPITAL STRUCTUREISSUER981910FOR98191FOR19 CONSTELLIUM SEF21107101FR001346747905/21/2026Powers to carry out formalitiesCORPORATE GOVERNANCEISSUER981910FOR98191FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i). Ari BousbibDIRECTOR ELECTIONSISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i). Carol J. BurtDIRECTOR ELECTIONSISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i). John G. DanhaklDIRECTOR ELECTIONSISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i). James A. FasanoDIRECTOR ELECTIONSISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i). Colleen A. GogginsDIRECTOR ELECTIONSISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i). William G. Kaelin Jr., M.D.DIRECTOR ELECTIONSISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i). John M. Leonard, M.D.DIRECTOR ELECTIONSISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i). Leslie Wims MorrisDIRECTOR ELECTIONSISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i). Sheila A. StampsDIRECTOR ELECTIONSISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay).SECTION 14A SAY-ON-PAY VOTESISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026Approve the adoption of the IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan.COMPENSATIONISSUER78520FOR7852FOR19 IQVIA HOLDINGS INC.46266C105US46266C105304/23/2026If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles.CORPORATE GOVERNANCESECURITY HOLDER78520AGAINST7852FOR19 MAXEON SOLAR TECHNOLOGIES, LTD.Y58473128SGXZ5772448608/29/2025To receive and adopt the Directors' Statement and Audited Financial Statements for the financial period ended 31 December 2024 and the Auditor's Report thereon.CORPORATE GOVERNANCEISSUER10FOR1FOR19 MAXEON SOLAR TECHNOLOGIES, LTD.Y58473128SGXZ5772448608/29/2025To re-elect Dr. Teo Tong Kooi as a Director and Member of Audit Committee, Compensation Committee, Strategy & Transformation Committee and Nominating and Corporate Governance Committee pursuant to Regulation 94 of the Constitution of the CompanyDIRECTOR ELECTIONSISSUER10FOR1FOR19 MAXEON SOLAR TECHNOLOGIES, LTD.Y58473128SGXZ5772448608/29/2025To approve Dr. Teo Tong Kooi's Directors' annual fees of US$254,000 to be paid pro rata on a quarterly basis, based on the Company's Outside Director Compensation Policy.COMPENSATIONISSUER10FOR1FOR19 MAXEON SOLAR TECHNOLOGIES, LTD.Y58473128SGXZ5772448608/29/2025To appoint (i) NLA DFK Assurance PAC as the statutory auditors of the Company in place of the retiring statutory auditor, Ernst & Young LLP, to hold office until the conclusion of the next annual general meeting pursuant to section 205 of the Companies Act 1967 of Singapore; & (ii) Marcum Asia CPAs LLP as auditor of the Company for other applicable reporting requirements under the relevant securities rules and regulations which the Company is subject to as a NASDAQ-listed company, and to authorize the Directors of the Company to fix their respective remuneration.AUDIT-RELATEDCOMPENSATIONISSUER10FOR1FOR19 MAXEON SOLAR TECHNOLOGIES, LTD.Y58473128SGXZ5772448608/29/2025To authorize Directors to issue shares.CAPITAL STRUCTUREISSUER10FOR1FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: Charles N. MillsDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: Joseph P. BarattaDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: Jacob D. BestDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: Todd M. BluedornDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: James M. BoyleDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: Richard A. GalantiDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: Patrick J. HealyDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: Andrew J. MillsDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: Robert R. SchmidtDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: Anushka M. SunderDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: Thomas W. SweetDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026DIRECTOR: Stephen H. WiseDIRECTOR ELECTIONSISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026Advisory Vote to Approve Our Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER66120FOR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026Advisory Vote on the Frequency of Votes on Our Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER661201 YEAR6612FOR19 MEDLINE INC.58507V107US58507V107006/11/2026Ratification of the Selection of Ernst & Young LLP as Our Independent Auditor for Fiscal Year 2026.AUDIT-RELATEDISSUER66120FOR6612FOR19 VICI PROPERTIES INC.925652109US925652109004/28/2026Election of Directors. James R. AbrahamsonDIRECTOR ELECTIONSISSUER1824250FOR182425FOR19 VICI PROPERTIES INC.925652109US925652109004/28/2026Election of Directors. Diana F. CantorDIRECTOR ELECTIONSISSUER1824250FOR182425FOR19 VICI PROPERTIES INC.925652109US925652109004/28/2026Election of Directors. Monica H. DouglasDIRECTOR ELECTIONSISSUER1824250FOR182425FOR19 VICI PROPERTIES INC.925652109US925652109004/28/2026Election of Directors. Elizabeth I. HollandDIRECTOR ELECTIONSISSUER1824250FOR182425FOR19 VICI PROPERTIES INC.925652109US925652109004/28/2026Election of Directors. Craig MacnabDIRECTOR ELECTIONSISSUER1824250FOR182425FOR19 VICI PROPERTIES INC.925652109US925652109004/28/2026Election of Directors. Edward B. PitoniakDIRECTOR ELECTIONSISSUER1824250FOR182425FOR19 VICI PROPERTIES INC.925652109US925652109004/28/2026Election of Directors. Michael D. RumbolzDIRECTOR ELECTIONSISSUER1824250FOR182425FOR19 VICI PROPERTIES INC.925652109US925652109004/28/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1824250FOR182425FOR19 VICI PROPERTIES INC.925652109US925652109004/28/2026To approve (on a non-binding, advisory basis) the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1824250FOR182425FOR19